Multiple Sclerosis Center of Northeastern New York
4 clinical trials · Sponsor
◉ Watch Multiple Sclerosis Center of Northeastern New York
| Record | Firm | Date |
|---|---|---|
| Analysis of MS Patients Who Have Had Greater Than 60 Infusions of Natalizumab (NCT04964700) | Multiple Sclerosis Center of Northeastern New York | 2021-05-06 |
Track Multiple Sclerosis Center of Northeastern New York automatically
Every clearance here is in the API, with alerts when new ones post.